Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noradrenergic Augmentation of SSRI Therapy in Patients With Depression Unresponsive or Incompletely Responsive to SSRI Monotherapy

NCT00485862 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00485862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00485862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noradrenergic Augmentation of SSRI Therapy in Patients With Depression Unresponsive or Incompletely Responsive to SSRI Monotherapy
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
January 31, 2005
Enrollment
214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms